SLQT
SelectQuote, Inc.
$1.12
-1.75%
2026-05-08
About SelectQuote, Inc.
SelectQuote, Inc. operates a technology-enabled, direct-to-consumer distribution and engagement platform that sells insurance policies and healthcare services in the United States. The company operates through three segments: Senior, Healthcare Services, and Life. It offers medicare advantage, medicare supplement, medicare part D, and other ancillary senior health insurance-related products, as well as engages in lead generation business; term life, final expense, and other ancillary products; non-commercial auto and home, property, and casualty insurance products. The company also provides SelectRx, a patient-centered pharmacy; Healthcare Select, which uses data from personal health risk and lifestyle assessment; HomeTM (PCPH), an accredited pharmacy; SelectPatient Management (SPM), a platform that helps patients navigate their chronic conditions and manage them using a treatment plan; and individual automobile and homeowners' insurance. SelectQuote, Inc. was incorporated in 1999 and is headquartered in Overland Park, Kansas.
Key Fundamentals
Forward P/E
5.97
EPS (TTM)
$-0.01
ROE
15.0%
Revenue Growth (YoY)
5.6%
Profit Margin
5.6%
Debt/Equity
61.02
Price/Book
0.56
Beta
1.61
Market Cap
$200.2M
Avg Volume (10D)
4.1M
Recent Breakout Signals
Recent Price Range (60 Days)
60D High
$1.39
60D Low
$0.56
Avg Volume
1.6M
Latest Close
$1.12
Get breakout alerts for SLQT
Sign up for Breakout Scanner to receive daily notifications when SLQT triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial. No card required.
SelectQuote, Inc. (SLQT) is listed on the New York Stock Exchange (NYSE). Breakout Scanner monitors SLQT daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. SLQT operates in the Financial Services sector within the Insurance Brokers industry. Data is provided for informational purposes only and does not constitute financial advice.